In multivariate analysis, right-sided tumor location remained a strong predictor of VTE (OR 5.2; 95% CI 1.9-14.1; <i>p</i> = 0.001), along with anti-EGFR therapy. The gene discussed is EGFR; the disease is neoplasm.